{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:46:57Z","timestamp":1789706817775,"version":"4.0.1"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.0262","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T23:13:20Z","timestamp":1393629200000},"page":"471-475","source":"Crossref","is-referenced-by-count":10,"title":["Neurolymphomatosis in a Patient with Extranodal NK\/T-cell Lymphoma, Nasal-type: A Case Report and Literature Review"],"prefix":"10.2169","volume":"53","author":[{"given":"Ikuo","family":"Shimizu","sequence":"first","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Hamano","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Kirihara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hiroshima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Swerdlow E, Campo E, Harris NE, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. 4th ed. IARC, Lyon, 2008."},{"key":"2","unstructured":"2. Suzuki R, Suzumiya J, Yamaguchi M, et al. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol 21: 1032-1040, 2010."},{"key":"3","unstructured":"3. McLeod JG. Peripheral neuropathy associated with lymphomas, leukemias, and polycytemia vera. In: Peripheral Neuropathy. 3rd ed. Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, Eds. Saunders, Philadelphia, 1993: 1591-1598."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wills AJ, O'Connor S, McMillan A. Sub-acute demyelinating neuropathy associated with an NK\/T cell lymphoma. J Neurol Neurosurg Psychiatry 79: 484-485, 2008.","DOI":"10.1136\/jnnp.2007.133694"},{"key":"5","unstructured":"5. Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115: 5005-5011, 2010."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Salm LP, Van der Hiel B, Stokkel MP. Increasing importance of <sup>18<\/sup>F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun 33: 907-916, 2012.","DOI":"10.1097\/MNM.0b013e3283561881"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25: 579-586, 2007.","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"8","unstructured":"8. Kim J, Kim YS, Lee EJ, Kang CS, Shim SI. Primary CD56-positive NK\/T-cell lymphoma of median nerve: a case report. J Korean Med Sci 13: 331-333, 1998."},{"key":"9","unstructured":"9. Odabasi Z, Parrott JH, Reddy VV, Oh SJ. Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J Peripher Nerv Syst 6: 197-203, 2001."},{"key":"10","unstructured":"10. Ishida F, Ko YH, Kim WS, et al. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation. Cancer Sci 103: 1079-1083, 2012."},{"key":"11","unstructured":"11. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24: 612-618, 2006."},{"key":"12","unstructured":"12. Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 29: 4410-4416, 2011."},{"key":"13","unstructured":"13. Pfreundschuh M, Tr&uuml;mper L, &Ouml;sterborg A, et al; MabThera International Trial (MInT) Group. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7: 379-391, 2006."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ito Y, Kimura H, Maeda Y, et al. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clin Cancer Res 18: 4183-4190, 2012.","DOI":"10.1158\/1078-0432.CCR-12-1064"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/5\/53_53.0262\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:49:55Z","timestamp":1621446595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/5\/53_53.0262\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.0262","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}